Illness management and recovery: Clinical outcomes of a randomized clinical trial in community mental health centers

被引:19
作者
Dalum, Helle Stentoft [1 ,2 ]
Waldemar, Anna Kristine [3 ]
Korsbek, Lisa [3 ]
Hjorthoj, Carsten [4 ]
Mikkelsen, John Hegel [1 ]
Thomsen, Karin [5 ]
Kistrup, Kristen [1 ]
Olander, Mette [6 ]
Lindschou, Jane [7 ]
Nordentoft, Merete [4 ]
Eplov, Lene Falgaard [4 ]
机构
[1] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Frederiksberg, Copenhagen, Denmark
[2] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Ballerup, Copenhagen, Denmark
[3] Mental Hlth Serv Capital Reg Denmark, Competence Ctr Recovery & Rehabil, Mental Hlth Ctr Ballerup, Copenhagen, Denmark
[4] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Copenhagen, Res Unit, Copenhagen, Denmark
[5] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Hvidovre, Copenhagen, Denmark
[6] Municipal Roskilde, Roskilde, Denmark
[7] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark
来源
PLOS ONE | 2018年 / 13卷 / 04期
关键词
GLOBAL ASSESSMENT; RATING-SCALE; INTERVENTION; RELIABILITY; PROGRAM; SAMPLE; GAF;
D O I
10.1371/journal.pone.0194027
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Illness Management and Recovery (IMR) is a psychosocial intervention with a recovery-oriented approach. The program has been evaluated in different settings; however evidence for the effects of IMR is still deficient. The aim of this trial was to investigate the benefits and harms of the IMR program compared with treatment as usual in Danish patients with schizophrenia or bipolar disorder. Method The trial was designed as a randomized, assessor-blinded, multi-center, clinical trial investigating the IMR program compared with usual treatment. 198 people diagnosed with schizophrenia or bipolar disorder participated. The primary outcome was the Global Assessment of Functioning (GAF-F) at the end of intervention and the secondary and explorative outcomes included severity of symptoms and service utilization. Results IMR had no significant effect on functioning, symptoms, substance use or service utilization. Conclusion This randomized trial contributes to the evidence base of IMR by providing a methodological solid base for its conclusions; however the trial has some important limitations. More research is needed to get a firm answer on the effectiveness of the IMR.
引用
收藏
页数:15
相关论文
共 30 条
  • [1] MINIMUM CLINICALLY IMPORTANT DIFFERENCE IN THE GLOBAL ASSESSMENT FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA
    Amri, I
    Millier, A.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A765 - A766
  • [2] Industry Sponsorship and Research Outcome A Cochrane Review
    Bero, Lisa
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (07) : 580 - 581
  • [3] Social functioning as an outcome measure in schizophrenia studies
    Burns, T.
    Patrick, D.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2007, 116 (06) : 403 - 418
  • [4] FURTHER-STUDIES ON INTERVIEWER TRAINING AND INTER-RATER RELIABILITY OF PRESENT-STATE-EXAMINATION (PSE)
    COOPER, JE
    COPELAND, JRM
    BROWN, GW
    HARRIS, T
    GOURLAY, AJ
    [J]. PSYCHOLOGICAL MEDICINE, 1977, 7 (03) : 517 - 523
  • [5] Illness management and recovery (IMR) in Danish community mental health centres
    Dalum, Helle Stentoft
    Korsbek, Lisa
    Mikkelsen, John Hagel
    Thomsen, Karin
    Kistrup, Kristen
    Olander, Mette
    Hansen, Jane Lindschou
    Nordentoft, Merete
    Eplov, Lene Falgaard
    [J]. TRIALS, 2011, 12
  • [6] Dalum HS, 2016, J MENT HEALTH, P1
  • [7] Power and sample size calculations for studies involving linear regression
    Dupont, WD
    Plummer, WD
    [J]. CONTROLLED CLINICAL TRIALS, 1998, 19 (06): : 589 - 601
  • [8] Färdig R, 2011, PSYCHIAT SERV, V62, P606, DOI 10.1176/ps.62.6.pss6206_0606
  • [9] Gingerich S., 2005, EVIDENCE BASED MENTA, P395
  • [10] Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse - 18-month outcomes of a randomised controlled trial
    Haddock, G
    Barrowclough, C
    Tarrier, N
    Moring, J
    O'Brien, R
    Schofield, N
    Quinn, J
    Palmer, S
    Davies, L
    Lowens, I
    McGovern, J
    Lewis, S
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2003, 183 : 418 - 426